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Monolayers of MC3T3-E1 were cultured for 21D in aMEM + 10%FBS,
supplemented with BGP and AA. mRNA expression of typical chon-
drogenesis markers (Aggrecan (Agg), type II (Col2a1) and X (Col10a1))
collagens and osteogenic markers (Osterix (Osx), Osteocalcin (Ocn) and
Osteopontin (Opn)) were assessed by quantitative RT-PCR. We also
assessed mRNA expression of Wnts (-4, -5a, -5b, -11) and BMPs (-2, -4,
-6, -7). Quantiﬁcation of Alcian Blue, Safranin O, Sirius red and Alizarin
red staining were used to evaluate proteoglycans, collagens and
mineralized content respectively. Alkaline phosphatase (ALP) activity
allowed to monitor osteogenesis. SDS-PAGE was used to assess the
global glycosylation status. Western blot allowed to check canonical (b-
catenin) and non-canonical (Calmodulin-Kinase II) Wnt signaling, as
well as BMP signaling (Smad and MAPK).
Results: During early proliferation (D1-7) and late proliferation/pre-
hypertrophy phases (D7-14) of chondrogenesis, Col2a1 and Agg mRNA
strongly increased, but to a lesser extent in COG5-. Proteoglycan
staining intensity was lower in COG5-. BMP-4 levels progressively
increased and were signiﬁcantly higher in COG5-. This was consistent
with increased phosphorylation of Smad 1/5/8. Wnt-4, -5a and -5b
mRNA were evenly increased in both controls and COG5-. BMP-6 and
Col10a1 mRNA were increased at D14, but were signiﬁcantly lower in
COG5-. Wnt-11 mRNA increased in controls, but not in COG5-. In
mineralization phase (D14 to D21), Col10a1 mRNA and mineralization
were strongly increased, but to a lesser extent in COG5-. During
osteogenesis, Opn, Osx and Ocn mRNA were signiﬁcantly higher in
controls, alike Alizarin red staining and ALP activity. Protein analysis
suggested differences in global glycosylation status, in particular of Wnt
ligands.
Conclusions: COG5 defect reduces chondrogenesis and osteogenesis.
COG5 particularly affected glycosylation andWnt signaling, underlining
its critical role in the fate of cells from the articular chondrocyte-bone
unit in the course of OA.232
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Purpose: Interleukin-10 (IL-10) is a pleiotrophic immunoregulatory
cytokine that has been shown to be elevated in cartilage and synovium
of osteoarthritis and has a chondroprotective effect. However, the role
of IL-10 during endochondral bone formation has not been well eluci-
dated. We intended to investigate the effect of IL-10 on endochondral
bone formation.
Methods: Loss- and gain of IL-10 function in endochondral bone
formation was studied with IL-10 null mice and IL-10-treated E15.5
tibia organ cultures, respectively. Primary chondrocytes from long
bones of E15.5 mice were cultured with or without IL-10 (10 ng/ml),
and the effects of IL-10 on chondrocyte marker genes or proteins were
assessed by real-time polymerase chain reaction and Western blot
analysis. Proliferation of primary chondrocytes was determined by
MTT assay.
Results:Whole skeletal stain of IL-10 null mice did not show signiﬁcant
difference in gross development compared with WT littermates, except
reduced occipital bone formation. Treatment with IL-10 signiﬁcantly
increased the length of tibiae in organ culture. IL-10 caused an increase
of both proliferating and hypertrophic zone length compared to control
group, but the proportion of either zone relative to total growth plate
length was not different between IL-10-treated and control groups. IL-
10 induces chondrogenic and hypertrophic differentiation as well as
proliferation of chondrocytes in vitro. Real-time PCR data revealed that
IL-10 treatment resulted in slight but signiﬁcant increases in the mRNA
expression of both chondrogenic and hypertrophic marker genes,
including aggrecan, type 2 collagen, type 10 collagen, osteopontin, and
MMP-13. Also, IL-10 increased the expression of Sox9 and Runx2 at m-
RNA and protein level. MTT assay showed that IL-10 signiﬁcantly
increased a proliferation of chondrocytes.Conclusions: These data represent the ﬁrst evidence that IL-10 induces
the chondrogenesis, chondrocyte proliferation and hypertrophic
differentiation through Sox9 and Runx2.233
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Background/Purpose: Aging-associated changes in articular chon-
drocytes represent a major risk factor for cartilage degradation and
osteoarthritis (OA). The major signaling pathway that regulates cellular
aging and stress resistance is the Insulin/IGF-1 signaling pathway. In
this pathway, Forkhead-box class O (FoxO) transcription factors play
central roles in protein quality control, autophagy and cellular defenses
against oxidative stress. The objective of this study was to analyze
expression and activation of FoxO transcription factors in normal, aging
and OA cartilage.
Methods: Human knee joints from individuals ages 23-90 were ob-
tained at autopsy. The entire femoral condyles of knee joints were
harvested from 6 young normal donors (mean  SD ¼ 36.0  9.6 years
old, OA grade I). Aged knee joints were also obtained from 4 donors
(mean  SD ¼ 72.5  3.6 years) with no history of arthritis and normal
or minimally ﬁbrillated cartilage (OA grade I-II). OA human joints were
obtained from 4 donors (mean  SD ¼ 81.5  10.3 years, OA grade III-
IV). Knee joints were also obtained frommice at the age of 4, 12, and 24
months and following surgically induced OA. Expression of FoxO
proteins was analyzed by immunohistochemistry and western blotting.
Regulation of FoxO protein expression and activation was analyzed in
cultured chondrocytes stimulated with cytokines, growth factors and
oxidants.
Results: Human cartilage expressed predominantly FoxO1 and FoxO3
but not FoxO4 protein as detected by western blotting. Immunohis-
tochemistry showed that normal human articular cartilage expressed
FoxO1 and FoxO3 proteins more strongly in chondrocytes in the
superﬁcial and mid zone as compared to the deep zone. FoxO showed
mainly nuclear localization in young normal cartilage. Areas of
cartilage exposed to minimal versus maximal weightbearing showed
no signiﬁcant difference in young normal cartilage except for the
deep zone where FoxO3 was more strongly expressed. During human
joint aging, expression of FoxO1 and FoxO3 was markedly reduced in
the superﬁcial zone of cartilage regions exposed to maximal
weightbearing. In OA-affected cartilage, chondrocyte clusters showed
strong FoxO phosphorylation and cytoplasmic localization. Similar
patterns of FoxO expression in normal joints and changes in aging
and OA joints were observed in mouse models. In cultured chon-
drocytes, the longer-term (2-5 day) treatment with proinﬂammatory
cytokines IL-1b and TNF-a suppressed FoxO1 protein, while TGF-
b and PDGF increased FoxO1 and FoxO3 expression, respectively.
FoxO1 and FoxO3 phosphorylation was increased signiﬁcantly by
short-term (60 minutes) exposure to IL-1b, PDGF, b-FGF, IGF-1, and
the oxidant t-BHP.
Conclusions: Normal articular cartilage has a tissue speciﬁc signature of
FoxOs expression and activation. Aging and OA in humans and mice is
associated with profound changes in FoxO expression and activation.
These results suggest that changes in FoxO expression and activation
may be involved in cartilage aging and OA, and provide a foundation
upon which the function of FoxOs in cartilage homeostasis, aging and
OA can be examined.234
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Purpose: Damaged cartilage is increasingly recognised as a permissive
environment for neurovascular inﬁltration. Neuropeptides involved in
pain transmission in osteoarthritis, have recently been implicated in
cartilage breakdown and also in chondrocyte proliferation and
survival. We took an unbiased approach to explore the effect of
substance P and bradykinin on expression 95 genes which may be
important in cartilage breakdown including all members of the MMP,
